New gene therapy shows promise in ovarian cancer fight
Disease control
Ongoing
This study tests a new treatment called IMNN-001, a gene therapy given directly into the abdomen, combined with standard chemotherapy for people newly diagnosed with advanced ovarian, fallopian tube, or peritoneal cancer. The goal is to see if adding IMNN-001 helps delay cancer g…
Phase: PHASE1, PHASE2 • Sponsor: Imunon • Aim: Disease control
Last updated May 01, 2026 15:58 UTC